Patients Embrace GLP-1 Medications as a Step Forward in Obesity Treatment but Seek Guidance A recent survey reveals that patients view GLP-1 medications as progress in obesity treatment while seeking clearer guidance on long-term care and understanding of associated risks.

Patients Embrace GLP-1 Medications as a Step Forward in Obesity Treatment but Seek Guidance #USA #Menlo_Park #GLP-1 #Obesity_Treatment #Phenomix_Sciences

Over Half of GLP-1 Users Seek Medical Support Due to Side Effects, New Study Reveals A recent study by Phenomix Sciences highlights that more than half of GLP-1 users report requiring additional medical care due to side effects, indicating a significant need for personalized obesity treatment.

Over Half of GLP-1 Users Seek Medical Support Due to Side Effects, New Study Reveals #USA #Menlo_Park #GLP-1 #Obesity_Treatment #Phenomix_Sciences

Mayo Clinic and Phenomix Collaboration Enhances Personalized Obesity Treatment Using AI A groundbreaking study by Mayo Clinic and Phenomix reveals an AI algorithm's potential in predicting side effects of GLP-1 medications, paving the way for personalized obesity treatments.

Mayo Clinic and Phenomix Collaboration Enhances Personalized Obesity Treatment Using AI #USA #Menlo_Park #Mayo_Clinic #Phenomix_Sciences #GLP-1_Therapy

Phenomix Sciences and Mayo Clinic Unveil Revolutionary Obesity Research at DDW 2025 Discover groundbreaking obesity research from Phenomix Sciences and Mayo Clinic at DDW 2025, showcasing advancements in precision medicine for obesity treatment.

Phenomix Sciences and Mayo Clinic Unveil Revolutionary Obesity Research at DDW 2025 #Mayo_Clinic #Phenomix_Sciences #obesity_research